VASCULAR BETA-ADRENOCEPTOR-MEDIATED RELAXATION AND THE TONE OF THE TISSUE IN CANINE ARTERIES

被引：13

作者：

BEGONHA, R ^{[1
]}

MOURA, D ^{[1
]}

GUIMARAES, S ^{[1
]}

机构：

[1] FAC MED PORTO,DEPT THERAPEUT & PHARMACOL,P-4200 OPORTO,PORTUGAL

来源：

JOURNAL OF PHARMACY AND PHARMACOLOGY | 1995年 / 47卷 / 06期

关键词：

D O I：

10.1111/j.2042-7158.1995.tb05840.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The aim of the present investigation was to study the influence of the tone in the response to beta-adrenoceptor activation of four different canine arteries: coronary, pulmonary, mesenteric and splenic. Five different levels of tone were produced (of about 35, 50, 65, 80 and 95% of the maximum) by adding phenylephrine (0.6, 1.0, 2.0, 4.0, and 10 mu M, respectively) to the bath. In the coronary artery at spontaneous tone, low concentrations of noradrenaline or adrenaline (1-3 nM) caused either relaxation or contraction, while after induced tone, both noradrenaline and adrenaline caused concentration-dependent relaxations, noradrenaline being more potent (EC50 of 0.16 (0.13-0.20) and 0.38 (0.28-0.67) mu M, respectively; n = 6; P < 0.05). Only in the coronary artery did isoprenaline relax the tissue irrespective of the previous level of tone. In all the other arteries, isoprenaline was able to cause concentration-dependent relaxations only if the previous tone was submaximal. At 80% of the maximum, isoprenaline caused relaxation in the mesenteric and pulmonary arteries, but in the splenic artery it caused relaxation only when the tone was of about 65% of the maximum or less. While in the coronary artery atenolol and ICI-118,551 (erythro-DL 1(7-methylindan-4-yloxy)-3-isopropylaminobutan-2-ol) were equipotent in antagonizing isoprenaline, noradrenaline and adrenaline, in the other vessels ICI-118,551 was from 58 (splenic artery) to 525 (mesenteric artery) times more potent than atenolol against the isoprenaline relaxant effect. We conclude that: the tone of the vessel represents a critical factor deciding the sense of the response (coronary artery; low concentrations of noradrenaline or adrenaline), the level at which the relaxant effect is triggered (mesenteric = 80% vs splenic = 65%), and the magnitude of the relaxant effect (always). beta(2)-Adrenoceptors predominate in the mesenteric, pulmonary and splenic arteries, while beta(1)-adrenoceptors predominate in the coronary artery. It is unlikely that adrenaline is able to cause vasodilation in any of the vascular beds studied.

引用

页码：510 / 513

页数：4

共 22 条

[11]

Fleisch J.H., Maling H.M., Brodie B.B., β Receptor activity in aorta: variation with age and species, Circ. Res., 26, pp. 151-162, (1970)

[12]

Guimaraes S., Further study of the adrenoceptors of the saphenous vein of the dog: influence of factors which interfere with the concentrations of the agonists at the receptor level, Eur. J. Pharmacol., 34, pp. 9-19, (1975)

[13]

Guimaraes S., Postsynaptic α‐adrenoceptors in blood vessels: discrepancies between results obtained in vivo and in vitro, New Aspects of the Role of Adrenoceptors in the Cardiovascular System, pp. 129-138, (1986)

[14]

Guimaraes S., Paiva M.Q., Two different biophases for adrenaline released by electrical stimulation or tyramine from the sympathetic nerve endings of dog saphenous vein, Naunyn-Schmiedeberg's Archives of Pharmacology, 316, pp. 200-204, (1981)

[15]

Guimaraes S., Brandao F., Paiva M.Q., A study of the adrenoceptor‐mediated feedback mechanism by using adrenaline as a false transmitter, Naunyn-Schmiedeberg's Archives of Pharmacology, 305, pp. 185-188, (1978)

[16]

Guimaraes S., Mota A., Begonha R., The effectiveness of β‐adrenoceptor stimulation and the contribution of β<sub>1</sub>‐adrenoceptors increase from the proximal to the distal part of the canine saphenous vein, Naunyn-Schmiedeberg's Archives of Pharmacology, 347, pp. 596-600, (1993)

[17]

Guimaraes S., Moura D., Paiva M.Q., Vaz-Da-Silva M.J., Lack of pre‐ and postjunctional β‐adrenoceptor‐mediated effects in the canine saphenous vein at birth, J. Pharmacol. Exp. Ther., 268, pp. 990-995, (1994)

[18]

Hoffman B.B., Lefkowitz R.J., Catecholamines and sympathomimetic amines, Goodman and Gilman's The Pharmacological Basis of Therapeutics, pp. 187-220, (1990)

[19]

Ikezono K., Zerkowski H.-R., Beckeringh J.J., Michel M.C., Brodde O.-E., β <sub>2</sub>‐Adrenoceptor‐mediated relaxation of the isolated human saphenous vein, J. Pharmacol. Exp. Ther., 241, pp. 294-299, (1987)

[20]

Seamon K., Daly J.W., Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein, J. Biol. Chem., 256, pp. 9799-9801, (1981)

← 1 2 3 →